Detailed Narrative
Chemicals Turnaround and Capacity Expansion
The Chloro-Vinyl segment was the primary growth engine this quarter, with PBDIT rising to ₹177 crore from ₹33 crore YoY. This was driven by a 15% revenue increase and significant energy cost reductions following the commissioning of a 120 MW captive power plant and 44 MW of renewable energy. The company commissioned 850 TPD of caustic soda capacity in May 2024, though utilization for this new capacity is expected to be gradual, reaching 40-50% in the second half of FY25 due to domestic oversupply.
Sugar Margins Under Pressure
Despite a 6% increase in domestic sugar prices to ₹3,900 per quintal, the sugar business saw a 57% decline in PBDIT. Management attributed this to higher State Advised Prices (SAP) for sugarcane in Uttar Pradesh and lower recovery rates due to adverse climatic conditions. The lack of sugar exports compared to the previous year also weighed on profitability, although ethanol volumes provided a partial hedge with 15% growth.
Downstream Chemical Integration
DCM Shriram is aggressively moving downstream to improve chlorine integration and mitigate negative chlorine prices. The Hydrogen Peroxide plant is in trial runs and expected to commission in Q2 FY25, while the Epichlorohydrin (ECH) plant is slated for commercial production in Q3 FY25. Management targets increasing captive and pipeline chlorine consumption to 55%, which should stabilize ECU margins over the medium term⏳.
Fenesta and Agri-Business Resilience
Fenesta Building Systems continued its growth trajectory with a 7% revenue increase and a robust 20% growth in its order book. Shriram Farm Solutions (SFS) also performed well, with revenue up 15% and PBDIT nearly doubling to ₹20 crore. These segments provide diversified cash flows, although Fenesta saw some margin compression due to higher fixed costs associated with new factory setups and sales promotion.
Debt Profile and CAPEX Outlook
Net debt increased to ₹1,459 crore as the company nears the end of its current CAPEX cycle. Management expressed confidence in the balance sheet, noting that the major investments in Chemicals and Sugar are largely complete. Future growth will focus on optimizing these new assets and exploring further chlorine downstream opportunities, subject to board approval.